Latest Insider Transactions at Regeneron Pharmaceuticals, Inc. (REGN)
This section provides a real-time view of insider transactions for Regeneron Pharmaceuticals, Inc. (REGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REGENERON PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REGENERON PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
492
-1.67%
|
$370,476
$753.28 P/Share
|
|
Dec 08
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,261
-7.12%
|
$1,736,448
$768.54 P/Share
|
|
Dec 08
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+8.63%
|
$1,143,000
$381.92 P/Share
|
|
Dec 08
2022
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
218
-16.77%
|
$169,822
$779.0 P/Share
|
|
Dec 08
2022
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
218
+14.36%
|
$82,840
$380.95 P/Share
|
|
Dec 02
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
610
-0.69%
|
$462,380
$758.86 P/Share
|
|
Dec 01
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,890
-6.05%
|
$1,436,400
$760.35 P/Share
|
|
Dec 01
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+7.41%
|
$952,500
$381.92 P/Share
|
|
Dec 01
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-5.3%
|
$831,600
$756.19 P/Share
|
|
Dec 01
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+5.04%
|
$409,200
$372.46 P/Share
|
|
Dec 01
2022
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$75,900
$759.98 P/Share
|
|
Nov 23
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Open market or private sale
|
Direct |
11,972
-2.31%
|
$8,871,252
$741.95 P/Share
|
|
Nov 22
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Payment of exercise price or tax liability
|
Direct |
38,028
-47.19%
|
$28,178,748
$741.81 P/Share
|
|
Nov 22
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+38.29%
|
$18,900,000
$378.98 P/Share
|
|
Nov 15
2022
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
3,720
-0.31%
|
$2,715,600
$730.69 P/Share
|
|
Nov 14
2022
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
6,280
-9.36%
|
$4,684,880
$746.0 P/Share
|
|
Nov 14
2022
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.97%
|
$1,790,000
$179.13 P/Share
|
|
Nov 14
2022
|
Andrew J Murphy EVP Research |
SELL
Bona fide gift
|
Direct |
1,360
-2.33%
|
-
|
|
Nov 08
2022
|
Neil Stahl EVP Research and Development |
SELL
Bona fide gift
|
Direct |
330
-0.63%
|
-
|
|
Nov 08
2022
|
Michael S Brown Director |
SELL
Open market or private sale
|
Indirect |
500
-6.98%
|
$374,000
$748.49 P/Share
|
|
Nov 08
2022
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
3,995
-12.02%
|
$3,032,205
$759.78 P/Share
|
|
Nov 08
2022
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,995
+36.48%
|
$1,709,860
$428.4 P/Share
|
|
Nov 07
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Open market or private sale
|
Direct |
7,886
-3.72%
|
$5,875,070
$745.01 P/Share
|
|
Nov 04
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Payment of exercise price or tax liability
|
Direct |
26,114
-40.44%
|
$18,932,650
$725.84 P/Share
|
|
Nov 04
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
BUY
Exercise of conversion of derivative security
|
Direct |
34,000
+34.49%
|
$12,954,000
$381.92 P/Share
|
|
Nov 04
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-4.84%
|
$727,000
$727.82 P/Share
|
|
Nov 04
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+4.62%
|
$372,000
$372.46 P/Share
|
|
Nov 01
2022
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.05%
|
$75,500
$755.92 P/Share
|
|
Nov 01
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-5.3%
|
$825,000
$750.0 P/Share
|
|
Nov 01
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+5.04%
|
$409,200
$372.46 P/Share
|
|
Nov 01
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
482
-0.17%
|
$364,874
$757.9 P/Share
|
|
Oct 31
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,518
-4.94%
|
$1,140,018
$751.24 P/Share
|
|
Oct 31
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+6.11%
|
$762,000
$381.92 P/Share
|
|
Oct 26
2022
|
Christopher R. Fenimore SVP Finance & CFO |
BUY
Bona fide gift
|
Indirect |
871
+48.6%
|
-
|
|
Oct 26
2022
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Bona fide gift
|
Indirect |
871
-100.0%
|
-
|
|
Oct 17
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
358
-1.23%
|
$264,562
$739.5 P/Share
|
|
Oct 14
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,142
-3.78%
|
$848,506
$743.78 P/Share
|
|
Oct 14
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+4.73%
|
$571,500
$381.92 P/Share
|
|
Oct 05
2022
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Open market or private sale
|
Direct |
1,844
-10.09%
|
$1,381,156
$749.0 P/Share
|
|
Oct 03
2022
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
304
-0.24%
|
-
|
|
Oct 03
2022
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.04%
|
$72,100
$721.63 P/Share
|
|
Oct 03
2022
|
Craig B. Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
279
+50.0%
|
-
|
|
Oct 03
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-2.72%
|
$775,500
$705.39 P/Share
|
|
Oct 03
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+2.65%
|
$392,700
$357.69 P/Share
|
|
Oct 03
2022
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Open market or private sale
|
Direct |
3,346
-15.48%
|
$2,422,504
$724.0 P/Share
|
|
Oct 03
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
3,612
-61.42%
|
$2,593,416
$718.0 P/Share
|
|
Oct 03
2022
|
Marc Tessier Lavigne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,612
+38.05%
|
$1,491,756
$413.33 P/Share
|
|
Sep 30
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
3,428
-60.17%
|
$2,392,744
$698.0 P/Share
|
|
Sep 30
2022
|
Marc Tessier Lavigne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,428
+37.57%
|
$1,415,764
$413.33 P/Share
|
|
Sep 29
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
3,798
-7.63%
|
$2,635,812
$694.51 P/Share
|